Skip to content

Clinical trial of acupuncture for diabetic peripheral neuropathy

Clinical trial of acupuncture for diabetic peripheral neuropathy - Clinical trial of acupuncture for diabetic peripheral neuropathy

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000002588
Enrollment
20
Registered
2009-10-10
Start date
2009-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Peripheral Neuropathy

Interventions

Electroacucpuncture (3/20Hz) will be performed on upper and/or lower extremities once a week for seven consecutive weeks.

Sponsors

Department of Complementary and Alternative Medicine, Osaka University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who are diagnosed as Type1 or Type2 diabetes and have numbness/pain in the extremities. 2) Obtaining written informed consent. 3) No severe disfunction in the: liver, kidney, respiration and hematopoietic system.

Exclusion criteria

Exclusion criteria: 1) Patient who have any one of the following conditions; # neuropathic disorder such as sciatica # symptoms considered to be related with peripheral entrapment neuropathy such as tarsal tunnel syndrome. # Sensory disturbance related with cerebrovascular disease. # Disturbance in the peripheral circulation such as Raynaud's disease or arteriosclerosis obliterans (ASO). 2) Severely uncontrolled blood glucocse (HbA1c=>10%). 3) Currntly pregnant or possibility of pregnancy. 4) Psychiatric disordes or any kind of cognitive dysfunctions that make understanding of the participation to the trial difficult. 5) Other conditions that are not considered eligible by the physician.

Design outcomes

Primary

MeasureTime frame
Severity of numbness/pain in the extremities which was evaluated with a visual analog scale (VAS).

Secondary

MeasureTime frame
Severity of the symptom with a faces scale, McGill-Melzack Pain Questionnaire (MPQ), SF-36 (QOL), Profile of mood status (POMS), Nerve conduction velocity, sensory threshold (Semmes-Weinstein Monofilament test), Autonomic nerve function, Vibratory sensation threshold.

Countries

Japan

Contacts

Public ContactToshinori Ito

Osaka University Graduate School of Medicine Department of Complementary and Alternative Medicine

juki@CAM.med.osaka-u.ac.jp06-6879-3498

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026